Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | NERV | TARA | ||
| Company | Immune Design CS | Minerva Neuroscie | Artara Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 6.70 | 5.20 | ||
| High | 5.85 | 6.84 | 5.28 | ||
| Low | 5.84 | 6.09 | 5.06 | ||
| Latest | 5.85 | 6.57 | 5.13 | ||
| Change | unch | -0.26 | -0.13 | ||
| % Change | unch | -3.73% | -2.47% | ||
| Volume | 103,800 | 188,000 | 405,400 | ||
| 20-Day Average Volume | 409,005 | 207,450 | 573,540 | ||
| Previous Close | 5.85 | 6.83 | 5.26 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 6.09 | 5.16 | ||
| 20-Day Raw Stochastic | 100.00% | 60.74% | 44.00% | ||
| 20-Day Relative Strength | 88.63 | 52.69 | 45.69 | ||
| Weighted Alpha | -20.50 | +84.63 | -5.18 | ||
| Today's Opinion | 88% Buy | 88% Buy | 24% Sell | ||
| Previous Opinion | 88% Buy | 88% Buy | 8% Sell | ||
| Last Month's Opinion | 56% Buy | 80% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -2.30% since 04/17/26 | -5.70% since 04/17/26 | ||
| Low | 5.84 on 04/01/19 | 6.09 on 04/24/26 | 5.06 on 04/24/26 | ||
| High | 5.85 on 04/01/19 | 7.58 on 04/22/26 | 5.55 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | +8.86% since 03/24/26 | +2.40% since 03/24/26 | ||
| Low | 5.82 on 03/14/19 | 5.02 on 04/06/26 | 4.80 on 03/30/26 | ||
| High | 5.85 on 04/01/19 | 7.58 on 04/22/26 | 5.55 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | +65.62% since 01/23/26 | -17.12% since 01/23/26 | ||
| Low | 1.22 on 01/03/19 | 3.90 on 01/26/26 | 4.80 on 03/30/26 | ||
| High | 5.85 on 04/01/19 | 8.80 on 03/16/26 | 7.50 on 02/23/26 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | +39.89% since 10/24/25 | +0.59% since 10/24/25 | ||
| Low | 1.10 on 12/24/18 | 3.25 on 12/03/25 | 4.11 on 11/07/25 | ||
| High | 5.85 on 04/01/19 | 8.80 on 03/16/26 | 7.82 on 11/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 288,261 | 282,463 | ||
| Shares Outstanding, K | 48,365 | 43,842 | 55,061 | ||
| Annual Sales | 2,200,000 | 0 | 0 | ||
| Annual Net Income | -54,760,000 | -293,420,000 | -57,440,000 | ||
| Last Quarter Sales | 480,000 | 0 | 0 | ||
| Last Quarter Net Income | -13,600,000 | -283,670,000 | -17,310,000 | ||
| 60-Month Beta | 3.48 | -0.19 | 1.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.64 on 03/11/26 | -0.37 on 03/10/26 | ||
| Latest Earnings Date | 05/01/19 | 05/12/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||